Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders
Open accessThe DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Expansion of G4C2 repeats within the C9ORF72 gene is the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Such repeats lead to decreased expression of the autophagy regulator C9ORF72 protein. Furthermore, sense and antisense repeats are translated into toxic dipeptide repeat (DPR) proteins. It is unclear how these repeats are translated, and in which way their translation and the reduced expression of C9ORF72 modulate repeat toxicity. Here, we found that sense and antisense repeats are translated upon initiation at canonical AUG or near‐cognate start codons, resulting in polyGA‐, polyPG‐, and to a lesser degree polyGR‐DPR proteins. However, accumulation of these proteins is prevented by autophagy. Importantly, reduced C9ORF72 levels lead to suboptimal autophagy, thereby impairing clearance of DPR proteins and causing their toxic accumulation, ultimately resulting in neuronal cell death. Of clinical importance, pharmacological compounds activating autophagy can prevent neuronal cell death caused by DPR proteins accumulation. These results suggest the existence of a double‐hit pathogenic mechanism in ALS/FTD, whereby reduced expression of C9ORF72 synergizes with DPR protein accumulation and toxicity. An expansion of G4C2 repeats in the C9ORF72 gene causes amyotrophic lateral sclerosis (ALS). Here, cell transfection and mass spectrometry indicate that G4C2 repeats are translated through classical initiation to cognate ATG or near‐cognate start codons. Furthermore, impaired autophagy due to reduced expression of the C9ORF72 protein synergizes toxicity of G4C2 translation. ALS‐linked sense and antisense repeats are translated into toxic peptides that require clearance by C9ORF72‐dependent autophagy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Intriguingly, these two mechanisms may synergize in disease7.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [7]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, the loss of C9orf72 function and consequent impairment in autophagy may enhance DPR accumulation in C9orf72 mutation carriers, acting synergistically to accentuate neurodegeneration [154,172,173].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [172]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 1×
“ALS patients can present significant clinical, genetic, and histopathological overlaps with frontotemporal dementia (FTD), a presenile dementia affecting frontal and temporal brain regions (Lomen-Hoerth et al , 2002; Ringholz et al , 2005; Neumann et al , 2006).”
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 3×
“…expansion of GGGGCC (G4C2) repeats within the first intron of the C9ORF72 gene as the most common inherited cause for both ALS and FTD in Caucasian populations of northern Europe and North America (DeJesus-Hernandez et al , 2011; Renton et al , 2011; Gijselinck et al , 2012; Majounie et al , 2012).”
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409 · cited 1×
“…expansion of GGGGCC (G4C2) repeats within the first intron of the C9ORF72 gene as the most common inherited cause for both ALS and FTD in Caucasian populations of northern Europe and North America (DeJesus-Hernandez et al , 2011; Renton et al , 2011; Gijselinck et al , 2012; Majounie et al , 2012).”
Ingolia, N. T., Lareau, L. F., & Weissman, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.10.002 · Cited by 2,187 · cited 2×
“…form inclusions throughout the brain of patients with C9-ALS/FTD (Ash et al , 2013; Gendron et al , 2013; Mori et al , 2013; Zu et al , 2013), as well as in mice expressing expanded G4C2 repeats (Chew et al , 2015; O’Rourke et al , 2015; Peters et al , 2015; Jiang et al , 2016; Liu et al , 2016).”
Autophagy modulation as a potential therapeutic target for diverse diseases
Rubinsztein, D. C., Codogno, P., & Levine, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3802 · Cited by 1,437
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S.-M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Van Broeckhoven, C., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,277
Majounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., Chiò, A., Restagno, G., Nicolaou, N., Simon-Sanchez, J., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70043-1 · Cited by 1,210 · cited 1×
“…expansion of GGGGCC (G4C2) repeats within the first intron of the C9ORF72 gene as the most common inherited cause for both ALS and FTD in Caucasian populations of northern Europe and North America (DeJesus-Hernandez et al , 2011; Renton et al , 2011; Gijselinck et al , 2012; Majounie et al , 2012).”
Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T., Lin, W.-L., DeJesus-Hernandez, M., van Blitterswijk, M. M., Jansen-West, K., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,100
The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang, K., Donnelly, C. J., Haeusler, A. R., Grima, J. C., Machamer, J. B., Steinwald, P., Daley, E. L., Miller, S. J., Cunningham, K. M., Vidensky, S., et al. (2015) · Nature · doi:10.1038/nature14973 · Cited by 982 · cited 1×
“…2017; Lopez-Gonzalez et al , 2019), nuclear and nucleolar organization (White et al , 2019; Zhang et al , 2019), and/or nucleocytoplasmic transport (Kwon et al , 2014; May et al , 2014; Mizielinska et al , 2014; Wen et al , 2014; Zhang et al , 2015, 2016; Freibaum et al , 2015; Jovi (cid:1) ci (cid”
C9orf72 nucleotide repeat structures initiate molecular cascades of disease
Haeusler, A. R., Donnelly, C. J., Periz, G., Simko, E. A. J., Shaw, P. G., Kim, M.-S., Maragakis, N. J., Troncoso, J. C., Pandey, A., Sattler, R., et al. (2014) · Nature · doi:10.1038/nature13124 · Cited by 978 · cited 1×
“…foci that recruit various RNA-binding proteins, potentially altering their localization and functions (Almeida et al , 2013; Donnelly et al , 2013; Lagier-Tourenne et al , 2013; Lee et al , 2013; Mizielinska et al , 2013; Cooper-Knock et al , 2014; Haeusler et al , 2014; Conlon et al , 2016, 2018).”
Cited by
Root, J., Merino, P., Nuckols, A., Johnson, M., & Kukar, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105360 · Cited by 238
Autophagy and ALS: mechanistic insights and therapeutic implications
Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189
“acting synergistically to accentuate neurodegeneration [154,172,173].”
CRISPR-based functional genomics for neurological disease
Kampmann, M. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0373-z · Cited by 163
Macroautophagy in CNS health and disease
Griffey, C. J., & Yamamoto, A. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00588-3 · Cited by 153
C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation
Lall, D., Lorenzini, I., Mota, T. A., Bell, S., Mahan, T. E., Ulrich, J. D., Davtyan, H., Rexach, J. E., Muhammad, A. K. M. G., Shelest, O., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.05.020 · Cited by 147
Autophagy in health and disease: From molecular mechanisms to therapeutic target
Lu, G. X., Wang, Y., Shi, Y. P., Zhang, Z., Huang, C., He, W., Wang, C., & Shen, H. (2022) · MedComm · doi:10.1002/mco2.150 · Cited by 149
Molecular and Cellular Mechanisms Affected in ALS
Le Gall, L., Anakor, E., Connolly, O., Vijayakumar, U., Duddy, W., & Duguez, S. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030101 · Cited by 145
Beckers, J., Tharkeshwar, A. K., & Van Damme, P. (2021) · Autophagy · doi:10.1080/15548627.2021.1872189 · Cited by 124
Understanding Amyotrophic Lateral Sclerosis: Pathophysiology, Diagnosis, and Therapeutic Advances
Rizea, R. E., Corlatescu, A.-D., Costin, H. P., Dumitru, A. V., & Ciurea, A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189966 · Cited by 95
C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD?
Braems, E., Swinnen, B., & Bosch, L. V. D. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02214-x · Cited by 84
Zhong, S., Lian, Y., Luo, W., Luo, R., Wu, X., Ji, J., Ji, Y., Ding, J., & Wang, X. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02375-3 · Cited by 79
Ababneh, N. A., Scaber, J., Flynn, R., Douglas, A. G. L., Barbagallo, P., Candalija, A., Turner, M. R., Sims, D., Dafinca, R., Cowley, S. A., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa106 · Cited by 77
RNA-mediated toxicity in C9orf72 ALS and FTD
McEachin, Z. T., Parameswaran, J., Raj, N., Bassell, G. J., & Jiang, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105055 · Cited by 67
Chen, J., Bassot, A., Giuliani, F., & Simmen, T. (2021) · Cells · doi:10.3390/cells10071789 · Cited by 63
The role of DNA damage response in amyotrophic lateral sclerosis
Sun, Y., Curle, A. J., Haider, A. M., & Balmus, G. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200002 · Cited by 62
Liu, Y., Andreucci, A., Iwamoto, N., Yin, Y., Yang, H., Liu, F., Bulychev, A., Hu, X. S., Lin, X., Lamore, S. D., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.007 · Cited by 61
Mizielinska, S., Hautbergue, G. M., Gendron, T. F., van Blitterswijk, M., Hardiman, O. M., Ravits, J., Isaacs, A. M., & Rademakers, R. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00026-2 · Cited by 59
dCas13-mediated translational repression for accurate gene silencing in mammalian cells
Apostolopoulos, A., Kawamoto, N., Chow, S. Y. A., Tsuiji, H., Ikeuchi, Y., Shichino, Y., & Iwasaki, S. (2024) · Nature Communications · doi:10.1038/s41467-024-46412-7 · Cited by 56
Banerjee, P., Mehta, A. R., Nirujogi, R. S., Cooper, J., James, O. G., Nanda, J., Longden, J., Burr, K., McDade, K., Salzinger, A., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq0651 · Cited by 54
Gleason, A. C., Ghadge, G. D., Chen, J., Sonobe, Y., & Roos, R. P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0256411 · Cited by 54
Sonobe, Y., Aburas, J., Krishnan, G., Fleming, A. C., Ghadge, G. D., Islam, P., Warren, E. C., Gu, Y., Kankel, M. W., Brown, A. E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26303-x · Cited by 50
Quaegebeur, A., Glaria, I., Lashley, T., & Isaacs, A. M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01036-y · Cited by 48
Yang, Q., Jiao, B., & Shen, L. H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.562758 · Cited by 47
Zhang, S., Tong, M., Zheng, D., Huang, H., Li, L., Ungermann, C., Pan, Y., Luo, H., Lei, M., Tang, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42003-0 · Cited by 45
RAN Translation of the Expanded CAG Repeats in the SCA3 Disease Context
Jazurek, M., Ciesiołka, A., Komur, A. A., Urbanek-Trzeciak, M. O., Krzyżosiak, W. J., & Fiszer, A. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.10.033 · Cited by 44
Neuronal polyunsaturated fatty acids are protective in ALS/FTD
Giblin, A., Cammack, A. J., Blomberg, N., Anoar, S., Mikheenko, A., Carcolé, M., Atilano, M. L., Hull, A., Shen, D., Wei, X., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01889-3 · Cited by 42
C9orf72 hexanucleotide repeat expansions impair microglial response in ALS
Masrori, P., Bijnens, B., Fumagalli, L., Davie, K., Poovathingal, S. K., Meese, T., Storm, A., Hersmus, N., Fazal, R., van den Biggelaar, D., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02075-1 · Cited by 42
Trinucleotide CGG Repeat Diseases: An Expanding Field of Polyglycine Proteins?
Boivin, M., & Charlet‐Berguerand, N. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.843014 · Cited by 42
Self-citationAn interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD
Bauer, C. S., Cohen, R. N., Sironi, F. M., Livesey, M. R., Gillingwater, T. H., Highley, J. R., Fillingham, D. J., Coldicott, I., Smith, E. F., Gibson, Y., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02470-z · Cited by 40
Božič, J., Motaln, H., Pucer, A., Markič, L., Tripathi, P., Yamoah, A., Aronica, E., Lee, Y., Heilig, R., Fischer, R., et al. (2021) · Brain · doi:10.1093/brain/awab300 · Cited by 39
Amino acid sensing and lysosomal signaling complexes
Cui, Z., Joiner, A. M. N., Jansen, R. M., & Hurley, J. H. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102544 · Cited by 38
Casterton, R., Hunt, R. J., & Fanto, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.02.018 · Cited by 38
Neurodegenerative diseases and immune system: From pathogenic mechanism to therapy
Chen, Y., Yin, P., Chen, Q., Zhang, Y., Tang, Y., Jin, W., & Yu, L. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00274 · Cited by 38
Diab, R., Pilotto, F., & Saxena, S. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1086895 · Cited by 37
Structural basis for the ARF GAP activity and specificity of the C9orf72 complex
Su, M.-Y., Fromm, S. A., Remis, J. P., Toso, D. B., & Hurley, J. H. (2021) · Nature Communications · doi:10.1038/s41467-021-24081-0 · Cited by 36
Frottin, F., Pérez‐Berlanga, M., Hartl, F. U., & Hipp, M. S. (2021) · eLife · doi:10.7554/elife.62718 · Cited by 36
Autophagy in ageing and ageing-related neurodegenerative diseases
Karabiyik, C., Frake, R. A., Park, S. J., Tanasa, M. P., & Rubinsztein, D. C. (2021) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2021.05 · Cited by 36
UPF1 reduces C9orf72 HRE-induced neurotoxicity in the absence of nonsense-mediated decay dysfunction
Zaepfel, B. L., Zhang, Z., Maulding, K., Coyne, A. N., Cheng, W., Hayes, L. R., Lloyd, T. E., Sun, S., & Rothstein, J. D. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108925 · Cited by 34
Sattler, R., Traynor, B. J., Robertson, J., Bosch, L. V. D., Barmada, S. J., Svendsen, C. N., Disney, M. D., Gendron, T. F., Wong, P. C., Turner, M. R., et al. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00548-8 · Cited by 34
Fujino, Y., Ueyama, M., Ishiguro, T., Ozawa, D., Ito, H., Sugiki, T., Murata, A., Ishiguro, A., Gendron, T. F., Mori, K., et al. (2023) · eLife · doi:10.7554/elife.84338 · Cited by 32
Martella, N., Pensabene, D., Varone, M., Colardo, M., Petraroia, M., Sergio, W., Rosa, P. L., Moreno, S., & Segatto, M. (2023) · Biomedicines · doi:10.3390/biomedicines11030750 · Cited by 31
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
Marchi, F. D., Franjkic, T., Schito, P., Russo, T., Nimac, J., Chami, A. A., Mele, A., Vidatic, L., Križ, J., Julien, J., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061599 · Cited by 31
Intercellular transmission of pathogenic proteins in ALS: Exploring the pathogenic wave
Arnold, F. J., Nguyen, A., Bedlack, R., Bennett, C. L., & Spada, A. R. L. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106218 · Cited by 31
Licata, N. V., Cristofani, R., Salomonsson, S. E., Wilson, K. M., Kempthorne, L., Vaizoglu, D., D’Agostino, V., Pollini, D., Loffredo, R., Pancher, M., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020105026 · Cited by 30
Ho, P., Hsieh, T., & Tsai, K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102441 · Cited by 29
Antisense, but not sense, repeat expanded RNAs activate PKR/eIF2α-dependent ISR in C9ORF72 FTD/ALS
Parameswaran, J., Zhang, N., Braems, E., Tilahun, K., Pant, D. C., Yin, K., Asress, S., Heeren, K., Banerjee, A., Davis, E., et al. (2023) · eLife · doi:10.7554/elife.85902 · Cited by 29
The RNA exosome complex degrades expanded hexanucleotide repeat RNA in C9orf72 FTLD/ALS
Kawabe, Y., Mori, K., Yamashita, T., Gotoh, S., & Ikeda, M. (2020) · The EMBO Journal · doi:10.15252/embj.2019102700 · Cited by 28
Boeynaems, S., Ma, X. R., Yeong, V., Ginell, G. M., Chen, J.-H., Blum, J. A., Nakayama, L., Sanyal, A., Briner, A., Haver, D. V., et al. (2023) · SSRN Electronic Journal · doi:10.1101/2023.03.09.531820 · Cited by 28
Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patients
Xie, Q., Li, K., Chen, Y., Li, Y., Jiang, W., Cao, W., Yu, H., Fan, D., & Deng, B. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00477-6 · Cited by 27
Kempthorne, L., Vaizoglu, D., Cammack, A. J., Carcolé, M., Roberts, M. J., Mikheenko, A., Fisher, A., Suklai, P., Muralidharan, B., Kroll, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55550-x · Cited by 27
RAB39B's role in membrane traffic, autophagy, and associated neuropathology
Tang, B. L. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29962 · Cited by 27
de Calbiac, H., Renault, S., Haouy, G., Jung, V. A., Roger, K., Zhou, Q., Campanari, M., Chentout, L., Demy, D. L., Marian, A., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2358736 · Cited by 24
How villains are made: The translation of dipeptide repeat proteins in C9ORF72-ALS/FTD
Spijker, H. M. V. ‘., & Almeida, S. (2023) · Gene · doi:10.1016/j.gene.2023.147167 · Cited by 24
Mori, K., Gotoh, S., Yamashita, T., Uozumi, R., Kawabe, Y., Tagami, S., Kamp, F., Nuscher, B., Edbauer, D., Haass, C., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101120 · Cited by 24
RAN proteins in neurodegenerative disease: Repeating themes and unifying therapeutic strategies
Guo, S., Nguyen, L., & Ranum, L. P. W. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.11.001 · Cited by 24
The molecular pathogenesis of repeat expansion diseases
Fujino, Y., & Nagai, Y. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200143 · Cited by 21
Partners in crime: Proteins implicated in RNA repeat expansion diseases
Baud, A., Derbis, M., Tutak, K., & Sobczak, K. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1709 · Cited by 21
Lin, C., Wu, H.-E., Weng, E. F.-J., Wu, H.-C., Su, T., & Wang, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03885-9 · Cited by 20
The Current Potential Pathogenesis of Amyotrophic Lateral Sclerosis
Jiang, S., & Xu, R. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04269-3 · Cited by 19
Zheng, W., Wang, K., Wu, Y., Ge, Y., Zhang, C., Li, Z., Wang, L., & Chen, S. (2022) · Theranostics · doi:10.7150/thno.76138 · Cited by 20
Development of a specific live-cell assay for native autophagic flux
Safren, N., Tank, E. M. H., Malik, A. M., Chua, J. P., Santoro, N., & Barmada, S. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101003 · Cited by 20
Quezada, E. R., Cappelli, C., Díaz, I. D. P., Jury, N., Wightman, N., Brown, R. H., Montecino, M. A., & van Zundert, B. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01039-z · Cited by 18
A monocarboxylate transporter rescues frontotemporal dementia and Alzheimer’s disease models
Xu, D., Vincent, A. J., González‐Gutiérrez, A., Aleyakpo, B., Anoar, S., Giblin, A., Atilano, M. L., Adams, M. L., Shen, D., Thoeng, A., et al. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010893 · Cited by 17
Park, J. H., Chung, C. G., Seo, J., Lee, B., Lee, Y., Kweon, J. H., & Lee, S. B. (2020) · PubMed Central · doi:10.14348/molcells.2020.0130 · Cited by 17
Jun, Y., Lee, S., Ban, B.-K., Lee, J., & Gao, F. (2023) · Autophagy · doi:10.1080/15548627.2023.2169309 · Cited by 16
Thumbadoo, K. M., Dieriks, B. V., Murray, H. C., Swanson, M. E. V., Yoo, J. H., Mehrabi, N. F., Turner, C. P., Dragunow, M., Faull, R. L. M., Curtis, M. A., et al. (2024) · Brain · doi:10.1093/brain/awae140 · Cited by 16
Lampasona, A. A., Almeida, S., & Gao, F. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.030 · Cited by 16
Loss of TMEM106B exacerbates C9ALS/FTD DPR pathology by disrupting autophagosome maturation
Bauer, C. S., Webster, C. P., Shaw, A. C., Kok, J. R., Castelli, L. M., Lin, Y.-H., Smith, E. F., Illanes-Álvarez, F., Higginbottom, A., Shaw, P. J., et al. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1061559 · Cited by 15
Dane, T. L., Gill, A. L., Vieira, F. G., & Denton, K. R. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1134090 · Cited by 15
Sonobe, Y., Lee, S., Krishnan, G., Gu, Y., Kwon, D. Y., Gao, F., Roos, R. P., & Kratsios, P. (2023) · eLife · doi:10.7554/elife.83189 · Cited by 15
Structure of the human C9orf72-SMCR8 complex reveals a multivalent protein interaction architecture
Nörpel, J., Cavadini, S., Schenk, A. D., Graff-Meyer, A., Hess, D., Seebacher, J., Chao, J. A., & Bhaskar, V. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001344 · Cited by 14
Houghton, O. H., Mizielinska, S., & Gómez‐Suaga, P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.838402 · Cited by 14
C9orf72 Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age
Zanella, I., Zacchi, E., Piva, S., Filosto, M., Beligni, G., Alaverdian, D. A., Amitrano, S., Fava, F., Baldassarri, M., Frullanti, E., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136991 · Cited by 14
Sultana, J., Ragagnin, A., Parakh, S., Saravanabavan, S., Soo, K. Y., Vidal, M., Jagaraj, C. J., Ding, K., Wu, S., Shadfar, S., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04187-4 · Cited by 13
Miller, S. L., Green, K. M., Crone, B., Switzenberg, J. A., Tank, E. M. H., Krans, A., Jansen‐West, K. R., Wieland, C. M., Ji, E. W., Petrucelli, L., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2507334122 · Cited by 13
Bioenergetic and Autophagic Characterization of Skin Fibroblasts from C9orf72 Patients
Álvarez‐Mora, M. I., Garrabou, G., Barcos, T., Garcia‐García, F., Grillo-Risco, R., Peruga, E., Gort, L., Borrego‐Écija, S., Sánchez‐Valle, R., Cantó, J., et al. (2022) · Antioxidants · doi:10.3390/antiox11061129 · Cited by 12
Smeele, P. H., Cesare, G., & Vaccari, T. (2024) · Cells · doi:10.3390/cells13020178 · Cited by 12
Gotoh, S., Mori, K., Fujino, Y., Kawabe, Y., Yamashita, T., Omi, T., Nagata, K., Tagami, S., Nagai, Y., & Ikeda, M. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105703 · Cited by 12
Limanaqi, F., Busceti, C. L., Biagioni, F., Cantini, F., Lenzi, P., & Fornai, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114021 · Cited by 12
C9orf72 knockdown alleviates hepatic insulin resistance by promoting lipophagy
Cang, X., Wang, Y., Zeng, J., Gao, J., Yu, Q., Lu, C., Xu, F., Lin, J., Zhu, J., & Wang, X. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.12.018 · Cited by 12
Gagliardi, D., Costamagna, G., Taiana, M. M., Andreoli, L., Biella, F., Bersani, M., Bresolin, N., Comi, G. P., & Corti, S. P. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101172 · Cited by 12
C9orf72 protein quality control by UBR5‐mediated heterotypic ubiquitin chains
Jülg, J., Edbauer, D., & Behrends, C. (2023) · EMBO Reports · doi:10.15252/embr.202255895 · Cited by 11
Insights into AlphaFold’s breakthrough in neurodegenerative diseases
Mubeen, H., Masood, A., Zafar, A., Khan, Z. Q., Khan, M. Q., & Nisa, A. U. (2024) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-024-03721-6 · Cited by 11
Drosophila as a model to study autophagy in neurodegenerative diseases and digestive tract
Tzou, F., Wen, J., Yeh, J., Huang, S., Chen, G., & Chan, C. (2021) · IUBMB Life · doi:10.1002/iub.2583 · Cited by 11
PTPσ-mediated PI3P regulation modulates neurodegeneration in C9ORF72-ALS/FTD
Zhang, Z., Fu, X., Wright, N., Wang, W., Ye, Y., Asbury, J., Li, Y., Zhu, C., Wu, R., Wang, S., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.02.005 · Cited by 10
GC-rich repeat expansions: associated disorders and mechanisms
Schröder, C., Horsthemke, B., & Depienne, C. (2021) · Medizinische Genetik · doi:10.1515/medgen-2021-2099 · Cited by 10
Ito, H., Machida, K., Fujino, Y., Hasumi, M., Sakamoto, S., Nagai, Y., Imataka, H., & Taguchi, H. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf994 · Cited by 9
Ito, H., Machida, K., Hasumi, M., Ueyama, M., Nagai, Y., Imataka, H., & Taguchi, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-50188-z · Cited by 9
Xu, S., Ma, Q., Shen, J., Li, N., Sun, S., Wang, N., Chen, Y., Dong, C., Tam, K. Y., Prehn, J. H. M., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.02.004 · Cited by 9
C9orf72 proline-arginine dipeptide repeats disrupt the proteasome and perturb proteolytic activities
Zhang, Y., Nelson, S., Viera-Ortiz, A., Lee, E. B., & Fairman, R. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad078 · Cited by 9
Proteostasis deregulation as a driver of C9ORF72 pathogenesis
Torres, P., Cabral‐Miranda, F., Gonzalez‐Teuber, V., & Hetz, C. A. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15529 · Cited by 9
Lin, L. T., Shenouda, M., McGoldrick, P., Lau, A., & Robertson, J. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02061-5 · Cited by 8
Identification of selective and non-selective C9ORF72 targeting in vivo active siRNAs
Gilbert, J. W., Kennedy, Z., Godinho, B. M. D. C., Summers, A., Weiss, A., Echeverria, D., Bramato, B. M., McHugh, N., Cooper, D., Yamada, K., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102291 · Cited by 8
Multiple ways to a dead end: diverse mechanisms by which ALS mutant genes induce cell death
Tsai, Y.-L., & Manley, J. L. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1886661 · Cited by 8
Lee, D., Jeong, H. C., Kim, S. Y., Chung, J. Y., Cho, S. H., Kim, K. A., Cho, J. H., Ko, B. S., Cha, I. J., Chung, C. G., et al. (2023) · Molecules and Cells · doi:10.1016/j.mocell.2023.12.003 · Cited by 7
Hasumi, M., Ito, H., Machida, K., Niwa, T., Taminato, T., Nagai, Y., Imataka, H., & Taguchi, H. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108360 · Cited by 6
Genetic Basis of Motor Neuron Diseases: Insights, Clinical Management, and Future Directions
Antonakoudis, A., Kyriakoudi, S. A., Chatzi, D., Dermitzakis, I., Gargani, S., Meditskou, S., Μanthou, M. E., & Theotokis, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104904 · Cited by 6
Boyanova, S., Banks, G. T., Lipina, T. V., Bains, R. S., Forrest, H., Stewart, M. E., Carcolé, M., Milioto, C., Isaacs, A. M., Wells, S. E., et al. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052324 · Cited by 6
Mori, K., Gotoh, S., Uozumi, R., Miyamoto, T., Akamine, S., Kawabe, Y., Tagami, S., & Ikeda, M. (2023) · JMA Journal · doi:10.31662/jmaj.2022-0160 · Cited by 6
Aspects of degradation and translation of the expanded C9orf72 hexanucleotide repeat RNA
Mori, K., Gotoh, S., & Ikeda, M. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15847 · Cited by 6
Metadata
- Authors
- Boivin, M., Pfister, V., Gaucherot, A., Ruffenach, F., Negroni, L., Sellier, C., & Charlet‐Berguerand, N.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Sellier, Chantal
- Charlet‐Berguerand, Nicolas
- Venue
- The EMBO Journal
- Published
- 2020-01-13
- Volume
- 39
- Issue
- 4
- Pages
- e100574-e100574
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC7024836
- OpenAlex
- W2999593520
- Cited by
- 137
- References
- 106
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 19 · 2023: 30 · 2022: 14 · 2021: 29 · 2020: 17
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- Funders
- Agence Nationale de la Recherche (ANR‐10‐LABX‐0030‐INRT, ANR‐10‐IDEX‐0002‐02)
- European Research Council (ERC‐2012‐StG #310659)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- C9orf72, G4C2 repeat expansion, dipeptide repeat proteins, autophagy, amyotrophic lateral sclerosis, frontotemporal dementia, neuronal cell death, autophagy activators
- MeSH terms
- C9orf72 Protein, Amyotrophic Lateral Sclerosis, Autophagy, Dipeptides, Humans, Neurons, Proteins, Cell Death, DNA Repeat Expansion, Frontotemporal Dementia, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.